We are proud to host this program by The Estradiol Initiative.

The Prostate Cancer Foundation recently advocated to the FDA for approval of a new drug, capivasertib, for treating prostate cancer. It was approved 7-1, in large part due to the lobbying efforts of the CEO of the PCF, Gina B. Carithers.

We would like each Estradiol User to send an email to Ms. Carithers at PCF asking them to lobby for FDA approval of transdermal estradiol, based on the recent successful results reported in the New England Journal of Medicine paper by Langley, et al. (2026).

We attach a draft template email.  It would be great if you could personalize it, though, so that the PCF doesn’t get a bunch of identical email messages!